Understanding AM2: Potential Drug Target and Biomarker for Various Diseases

Target Name: Adrenomedullin receptor 2

NCBI ID: P12323

Adrenomedullin receptor 2

Other Name(s): AM2

Understanding AM2: Potential Drug Target and Biomarker for Various Diseases

Adrenomedullin receptor 2 (AM2) is a G protein-coupled receptor located on the surface of various tissues in the body. It plays a crucial role in the regulation of physiological processes such as cardiovascular function, blood pressure, and pain perception. AM2 is also a potential drug target and biomarker for various diseases, including heart failure, hypertension, and neurodegenerative disorders.

The AM2 receptor is a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play a significant role in cellular signaling. G protein-coupled receptors are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. They are characterized by the presence of a transmembrane glycoprotein that consists of an extracellular domain, a transmembrane segment, and an intracellular segment.

AM2 is a type of G protein-coupled receptor that is expressed in various tissues throughout the body, including the heart, kidneys, and brain. It is involved in the regulation of physiological processes such as heart rate, blood pressure, and pain perception. AM2 is also involved in the regulation of neurotransmitter release from neuroendocrine cells, which is critical for the function of the nervous system.

AM2 is a potential drug target for various diseases, including heart failure, hypertension, and neurodegenerative disorders. For example, recent studies have shown that AM2 is involved in the regulation of neurotransmitter release from neuroendocrine cells and that it may play a role in the development of neurodegenerative disorders. Additionally, AM2 has also been shown to be involved in the regulation of pain perception and may be a potential drug target for chronic pain.

In addition to its potential drug-targeting properties, AM2 is also a potential biomarker for various diseases. For example, recent studies have shown that AM2 is involved in the regulation of pain perception and that it may be a potential biomarker for chronic pain. Additionally, AM2 has also been shown to be involved in the regulation of neurotransmission and may be a potential biomarker for neurodegenerative disorders such as Alzheimer's disease.

In conclusion, AM2 is a G protein-coupled receptor that is involved in the regulation of various physiological processes in the body. It is a potential drug target for various diseases, including heart failure, hypertension, and neurodegenerative disorders. Additionally, AM2 is also a potential biomarker for these diseases and may be a valuable tool for the development of new treatments. Further research is needed to fully understand the role of AM2 in the regulation of physiological processes and its potential as a drug target and biomarker.

Protein Name: Adrenomedullin Receptor 2

The "Adrenomedullin receptor 2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Adrenomedullin receptor 2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets